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Abstract
Introduction Indices of collateral flow deficit derived from
MR perfusion imaging that are predictive of MCA-M1 recan-
alization after intravenous thrombolysis have been recently
reported. Our objective was to test the performance of such
MRI-derived collateral flow indices for prediction of recana-
lization after endovascular thrombectomy.
Methods Fifty-seven patients with MCA-M1 occlusion eval-
uated with multimodal MRI prior to thrombectomy were
included. Bayesian processing allowed quantification of col-
lateral perfusion indices like the volume of tissue with severe-
ly prolonged arterial-tissue delay (>6 s) (VolATD6). Baseline
DWI lesion volume was also measured. Correlations with
angiographic collateral flow grading and post-thrombectomy
recanalization were assessed.
Results VolATD6<27 ml or DWI lesion volume <15 ml pro-
vide the most accurate diagnosis of excellent collateral supply
(p <0.0001). The combination of VolATD6>27 ml and DWI
lesion volume >15 ml significantly discriminates recanalizers
versus nonrecanalizers (whole cohort, p=0.032; MERCI cohort
(n =50), p=0.024). When both criteria are positive, 76.2 % of
the patients treated with the MERCI retriever do not fully
recanalize (p=0.024). In multivariate analysis, the aforemen-
tioned combined criterion and the angiographic collateral grade
are the only independent predictors of recanalization with the
MERCI retriever (p=0.015 and 0.029, respectively).
Conclusion Bayesian arterial-tissue delay maps and DWI
maps provide a non-invasive assessment of the degree of
collateral flow and a combined index that is predictive of
MCA-M1 recanalization after endovascular thrombectomy.
Further studies are needed to evaluate the accuracy of this
index in patients treated with novel stent retriever devices.




nCCD Normalized collateral circulation deficit index
SVD Singular value decomposition
oSVD Singular value decomposition with oscillation
index
VolATD6 Volume of tissue with arterial-tissue delay higher
than 6 s
ATD Arterial-tissue delay
AIF Arterial input function
ACG Angiographic collateral flow grading
AOL Arterial occlusive lesion
TICI Thrombolysis in cerebral infarction
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Several studies have demonstrated that better collateral flow is
associated with a higher recanalization rate after endovascular
therapy [1, 2]. In addition, recanalization status represents the
strongest predictor of clinical outcome in patients after
thrombectomy [3]. Given that the current reference method
to evaluate the quality of collateral perfusion is the angiogra-
phy performed just before thrombectomy, non-invasive
methods are needed to predict recanalization and may also
facilitate selection of acute ischemic stroke patients for
endovascular therapy. Recent data from the literature suggest
that multimodal MRI could be part of this strategy.
The presence of hyperperfusion on pulsed arterial-spin-
labeling-type perfusion (ASL) is indicative of reperfusion/
collateral flow in acute ischemic stroke. However, ASL pro-
vides lower signal intensity than conventional T2* imaging
and ASL-derived CBF may not be sensitive to collateral flow
above a given value [4]. Territorial ASL can also be used
to noninvasively assess collateral circulation but is time-
consuming and more complex to perform in the emer-
gency management of an acute stroke [5]. In addition,
to date, no ASL study aiming to assess collateral flow
and predict recanalization after intravenous thrombolysis
or endovascular thrombectomy has been reported in the
literature.
More interestingly, Raychev et al. recently reported that the
baseline volume of DWI abnormalities was an independent
predictor of recanalization after thrombectomy in patients
with MCA and ICA occlusion [6]. Furthermore, MR-PWI-
derived indices of collateral circulation deficit have been
recently described in patients with acute MCA-M1 occlusion.
One, termed the nCCD index (normalized Collateral Circula-
tion Deficit index), is based on Tmax maps at different time
points and is calculated using a block-circulant SVD method
[7]. The other, named VolATD6 and strongly correlated with
nCCD, is based on arterial-tissue delay (ATD) maps accurate-
ly computed using a Bayesian algorithm and corresponds to
the volume of tissue with severely prolonged ATD (>6 s)
[8–10]. Indeed, in case of complete MCA-M1 occlusion, the
ATD, defined as the difference in bolus arrival time between
the arterial input function (AIF) and the tissue curve, is in-
creased in relation with a slow retrograde blood delivery
within the MCA territory during the arterial circulatory phase
[8, 9, 11]. These parameters, i.e., nCCD and VolATD6, are
both predictors of full MCA-M1 recanalization after IV
thrombolysis and are highly reproducible [7, 9]. However,
none of these indices have been tested yet to noninvasively
predict MCA-M1 recanalization after endovascular
thrombectomy.
The purpose of the current study is to test if MRI-derived
collateral flow indices could predict MCA-M1 recanalization
after thrombectomy.
As an initial step, a correlation study between the angio-
graphic collateral grade (ACG) and baseline volume of tissue
with prolonged ATD or DWI lesion volume was performed in
patients with acute MCA-M1 occlusion evaluated with MR-
PWI prior to angiography for thrombectomy.
Then, thresholds of tissue volume with prolonged ATD or
DWI lesion volume that optimally diagnose very good to
excellent collateral flow (angiographic collateral grade 3–4)
were determined. Moreover, the ability of the most accurate
parameters, alone or in combination, to differentiate
recanalizers versus non recanalizers was analyzed in the
whole cohort and in the subpopulation of patients treated with
MERCI retriever (Concentric Medical) only.
Finally, a multivariate analysis was performed to determine
if most discriminative parameters were independent predictors




Fifty-seven patients with acute MCA-M1 occlusion were
included in the study (Table 1). This cohort has already been
reported in a recent correlation study between MR-PWI-
derived collateral flow indices and the ACG [9]. These cases
were selected from a cohort of patients with acute MCA-M1
occlusion evaluated with MR-PWI prior to angiography for
thrombectomy and archived in a prospective single center
registry. Demographic, clinical, laboratory, and imaging data
were prospectively collected from 2003 to 2011 on consecu-
tive patients who received endovascular therapy for acute
cerebral ischemia. Institutional Review Board approval was
obtained for these analyses on collateral perfusion. All select-
ed patients have satisfactory-quality PWI records available for
analysis. ACG was performed blindly to clinical data by an
expert reader and evaluated with the American Society of
Interventional and Therapeutic Neuroradiology/Society of In-
terventional Radiology Collateral Flow Grading System on
baseline angiography [1]. Using this angiographic scale, pa-
tients are assigned to Grade 0 (no collaterals visible to the
ischemic site), 1 (slow collaterals to the periphery of the
ischemic site with persistence of some of the defect), 2 (rapid
collaterals to the periphery of ischemic site with persistence of
some of the defect and to only a portion of the ischemic
territory), 3 (collaterals with slow but complete angiographic
blood flow of the ischemic bed by the late venous phase), and
4 (complete and rapid collateral blood flow to the vascular bed
in the entire ischemic territory by retrograde perfusion). Pa-
tient population was divided into recanalizers and
nonrecanalizers depending on the degree of MCA-M1 recan-
alization after endovascular therapy (recanalizers = arterial
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occlusive lesion (AOL) 3 recanalization, i.e., full recanaliza-
tion; nonrecanalizers=AOL 0–2 recanalization, i.e., partial or
null recanalization [12, 13]). The degree of MCA recanaliza-
tion was angiographically assessed at the end of the
endovascular procedure.
Image acquisition and processing
MRI of patients treated by endovascular route were acquired
on a 1.5-T (Magnetom Vision+, Sonata or Symphony) or 3-T
(Magnetom Trio) MRI (Siemens Medical Systems, Erlangen,
Germany).
Diffusion-weighted images andMR perfusion images were
processed blindly to clinical data and to ACG, using a devel-
opment version of OleaSphere™ (Olea Medical, La Ciotat,
France). Diffusion was measured at three values of b (b =0,
500, 1,000 s/mm2). Average ADC maps were also generated.
The volume of diffusion anomalies was quantified from anal-
ysis of isotropic b1000 DW images and ADC maps.
Perfusion-weighted imaging (PWI) was performed using
an axial dynamic gradient-echo echo-planar perfusion-
weighted sequence (TR mean value of 2.12±0.29 s). After
automatic selection of the AIF [7], a systematic check of the
result was performed to be sure that the earliest AIF was
automatically selected in each case. The pre-bolus baseline
range was adjusted to reach the beginning of the AIF ascend-
ing slope. To increase the numerical accuracy of the Bayesian
estimation of hemodynamic parameters (CBF, CBV, MTT,
TTP, ATD), the step of the time grid used for the Bayesian
computation of the residue function was increased, by
introducing extra points between sampling time points, to
reach a minimum temporal resolution of 0.5 s [10]. The
mathematical algorithm of the Bayesian post-processing of
MR-PWI data used in the current study has been previously
detailed in Ref. [10].
Pixels corresponding to the CSF were automatically ex-
cluded using a brain tissue mask calculated from ADC maps
and large vessels were removed using a maximum CBV
threshold value of 7 or 8 ml/100 g, at the discretion of the
operator’s visual analysis.
Calculation of the Bayesian arterial-tissue delay maps
The Bayesian ATD is the time-to-maximum of the computed
Bayesian residue function R(t) [10]. The Bayesian method is a
robust probabilistic method for estimating the residue function
of brain tissues, R(t), and hemodynamic parameters [14]. The
Bayesian algorithm minimizes effects of oscillation, tracer
delay and low SNR during R(t) estimation when compared
with SVD methods [10, 14]. Indeed, severe overfitting and
oscillations induce a systematic underestimation of the first
values of the SVD-computed residue function which is respon-
sible for the SVD overestimation of the delay [15]. Conversely,
the Bayesian algorithm produces smoother estimate of the
residue function and allows to accurately measure delays be-
tween the AIF and the tissue curve [10, 15]. In addition, in
agreement with recommendations from the Acute Stroke Re-
search Imaging Roadmap II [16], simulations were performed
onMR digital phantom and confirmed that the ATD estimation
by means of the aforementioned Bayesian method is highly
accurate, even with a relatively high sampling time TR=2 s as
in the current study [10]. Besides, it is much more accurate by
comparison with the oSVD method (SVD with oscillation
index) [10]. These simulations also demonstrated only a slight
overestimation of the AIF-tissue delay by the Bayesian meth-
od, in case of strong dispersion only [10].
The whole volume of tissue with increased ATD, a priori
defined as the ipsilateral volume of tissue with ATD value>
contralateral hemispheric ATD mean value+1.5XATD stan-
dard deviation value, was measured (VolATD+1.5SD). Re-
sidual artifacts persisting after this ATD thresholding proce-
dure were manually excluded.
The volume of tissue with ATD>6 s (VolATD6) was also
determined to evaluate the severity of the collateral flow
deficit [8, 9]. The inter-rater reproducibility of this volume
measurement, assessed in a purposefully designed three-rater
study on 25 cases with acute MCA-M1 occlusion, is very high
(ICC(95 %CI)=0.994(0.988–0.997)) [9]. Measurements of
VolATD6 were automatically performed, without manual re-
moval of residual artifacts, since an ATD threshold value as
high as 6 s almost excludes the probability to include residual
artifacts in the volume of interest [9].




Sex ratio (M/F) 23/34
Diabetes (%) 24.6
Stroke etiology (CE/Atherom/Other) (%) 57.9/21/21
Onset-to-treatment time (min) 348.3 (178.1)
Baseline NIHSS 16.3 (5.7)
Onset-to-MRI time (min) 270.6 (166.7)
MRI-to-angiography time (min) 77.7 (41.6)
Baseline Vol DWI (ml) 34.3 (31)
Proximal MCA-M1 occlusion (%) 57.9
Distal MCA-M1 occlusion (%) 26.3
Tandem occlusion (%) 15.8
Combined IVT-IAT (%) 36.8
Thrombectomy (%) 100
Exclusive use of the MERCI retriever (%) 87.7
Full MCA-M1 recanalization during IAT (%) 47.4
CE cardioembolic etiology
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Measurements of VolATD+1.5SD and VolATD6 were per-
formed on the whole brain.
Measurement of baseline DWI lesion volume
The aim of this measurement was to determine the global
impact of acute hypoperfusion on brain tissue as detect-
able by diffusion imaging. Thereby, the ischemic lesion
was segmented from ADC and isotropic B1000 DWI
maps and the highest lesional volume of the two was
considered [7].
As an initial step, ADC threshold was set to 600×
10−6 mm2/s [17] then, this threshold was manually ad-
justed based on visual information from B1000 images.
Also ipsilateral and contralateral isolated artifacts were
removed only upon visual control with regard to the
B1000 image.
The inter-rater reproducibility of DWI lesion volume mea-
surements was assessed in a purposefully designed 3-rater
study on 48 patients with MCA-M1 occlusion already report-
ed in Ref. [7]. Three raters (one neuro-imaging expert and two
non-expert raters, fully blinded to clinical data) post-processed
all images. Pearson correlation tests were used to establish
inter-rater correlations. Intraclass correlation coefficients
(ICC) were calculated to establish the level of inter-rater
agreement. The standard deviation (SD) of differences be-
tween all raters’ measurements was also calculated to assess
volume measurement variability, as follows. First, all raters
(r =1:3) perform one volume measurement (Vrp) for each
patient (p =1:48). Since no gold standard is provided, the
mean of measures performed by the three raters was
calculated for each patient (mVp), followed by the dif-
ference of each measure to the corresponding mean
(dVrp=Vrp−mVp). SD on all these differences can be
calculated to assess interoperator uncertainty [17]. 2SD is
considered to be the confidence interval width at 95 %.
In this study, only the SD value was used to simplify
comparison with literature.
The inter-rater agreement for the lesion volume mea-
surement is perfect, whatever the rater’s expertise and the
correlations between raters’ measurements were also high
(r 2≥0.74) (Table 2). In addition, the SD of the differ-
ences in volumes calculation between all three operators
was 3.81 ml. These results are close to those of Ay et al.
[18] and Luby et al. [19] who reported standard devia-
tions of differences between two measurements of DWI
lesion (between examiners) of 5.1 ml and 5.41 to 7.2 ml
respectively.
Statistical analysis
The statistical analysis was performed blindly to clinical data.
All statistical tests were performed by means of JMP-9*
software (SAS Institute Inc., Cary, NC, USA).
The strength of the relationship between continuous quan-
titative variables like MR-PWI-derived parameters and a dis-
crete ordinal variable like ACGwas measured bymeans of the
Spearman’s rho correlation coefficient.
The comparison of group size was performed using
either a two-tail Fisher’s exact test for two statistical pop-
ulations or a Pearson’s chi square combined for three sta-
tistical populations. The strength of the association between
variables significantly correlated according to the Pearson’s
chi square test was measured using the Cramer’s V contin-
gency coefficient.
The Gaussian distribution of tested parameters was
assessed by a Shapiro–Wilk test.
A ROC analysis was performed to determine optimal
thresholds of Bayesian hemodynamic parameters providing
the best discrimination between angio grades 0–2 versus 3–4.
A ROC curve was generated for each Bayesian hemodynamic
parameter. For each curve, the area under the curve (AUC)
and optimal operating point were determined. The optimal
operating point, that determines the optimal threshold for a
given hemodynamic parameter, is the probability threshold
that gives the smallest false-positive rate (1−specificity) for
the largest true-positive rate (sensitivity). The Youden’s index,
defined as sensitivity+specificity−1, was also used to com-
pare the discriminative performance of each optimal
threshold.
A multivariate analysis was performed using multiple lo-
gistic regressions to determine the independent predictors of
MCA recanalization after thrombectomy. The results were
validated by means of a goodness-of-fit test. The statistical
significance threshold was set to p <0.05. A statistical trend
was defined as p <0.15.











ICC (95 % CI) 0.90(0.83–0.94) ↑↑ 0.78(0.64–0.87) ↑ 0.92(0.87–0.95) ↑↑ 0.86(0.79–0.91) ↑↑
r2 0.86 0.74 0.86 NA
↑↑ ICC value indicates perfect inter-rater agreement, ↑ ICC value indicates strong inter-rater agreement, NA not applicable
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Results
Details on patient population features and baseline character-
istics are presented in Table 1. Most of the patients were
treated with the MERCI retriever. Five patients were treated
with the PENUMBRA system (Penumbra Inc.) and only one
with the SOLITAIRE FR device (Covidien). Combined IV
and IA therapy was performed in about 37% of the cases. Full
MCA-M1 recanalization (AOL 3) was achieved in 47.4 % of
the cases. In the current series, 40.3 % of the patients were
included in a trial and had a documented mRS at 3 months
(56.5 % recanalizers, 43.5 % non recanalizers). At 3 months,
53.8 % of this subset of recanalizers and 20% of this subset of
non recanalizers were functionally independent (mRS 0–2). In
the whole cohort, four patients were assigned to ACG 0, 10 to
grade 1, 22 to grade 2, 14 to grade 3 and 7 to grade 4.
Considering the small sample size of grades 0 and 4 and to
improve the accuracy of the statistical comparison between
groups, patients included in angiographic collateral grades 0
and 1 (very bad collateral flow) were assigned to one group
named ACG 0–1 and patients included in angiographic col-
lateral grades 3 and 4 (very good collateral flow) were
assigned in another group named ACG 3–4. Therefore, the
statistical analysis was based on an ACG with only three
levels: 0–1 versus 2 versus 3–4 (Fig. 1).
A ROC analysis determined that optimal thresholds of
prolonged ATD tissue volume providing the best discrimina-
tion between angio grades 0–2 versus 3–4 were: VolATD6
threshold=27 ml (AUC=0.84; sensitivity=100 %; specifici-
ty=67%; Youden’s index=0.67) and VolATD+1.5SD thresh-
old=159 ml (AUC=0.75; sensitivity=81 %; specificity=
67 %, Youden’s index=0.48). A pre-treatment DWI lesion
volume value of 15 ml provides a clear-cut discrimination
between angiographic grades 0–2 versus 3–4 on box-plot
analysis (sensitivity=80 %; specificity=85.7 %; Youden’s
index=0.66) (Fig. 1).
VolATD6 and VolDWI optimal thresholds tend to more
accurately discriminate patients with very good collateral flow
and to better discriminate recanalizers versus non recanalizers
when compared with optimal threshold of VolATD+1.5SD
(Fig. 1, Tables 3 and 4).
The angographic collateral grading and the combination
of VolATD6 and DWI lesion volume measurements signif-
icantly discriminate recanalizers from nonrecanalizers,
whether patients are treated with the MERCI retriever only
or not (Table 4). When the VolATD6>27 ml and DWI>
15 ml combined criterion is positive in patients treated with
the MERCI retriever only, 76.2 % of the patients do not
fully recanalize (16/21) and 100 % of the patients are
assigned to angiographic grades 0–2 (absent to moderate
collateral circulation) (21/21) while 71 % are assigned to
angiographic grades 0–1 (absent to very poor collateral
circulation) (10/14).
When this criterion is negative, 57.1 % of the patients fully
recanalize (16/28) and 85.7 % of the patients are assigned to
groups 2–4 (moderate to excellent collateral circulation) (24/
28) while 57.1 % are assigned to angiographic grades 3–4
(very good to excellent collateral circulation) (10/14).
By comparison, in patients treated with the MERCI
retriever only, the angiographic grades 0–1 significantly
discriminate recanalizers versus nonrecanalizers. When
patients are assigned to these grades, 85.7 % of the
patients do not fully recanalize (12 over 14). Conversely,
if patients are assigned to grades 2–4, 55.5 % of the
patients fully recanalize (20 over 36).
Multivariate analysis
Since the recanalization rate depends on the retrieval device
used for thrombectomy [20, 21], this analysis was performed
on the MERCI cohort only (n =50).
The multiple logistic regression analysis including the an-
giographic collateral grade 0–2, the use of a combination
therapy, the presence of a tandem occlusion and the time-to-
IA therapy higher than 240 min shows that the ACG is the
only independent predictor of MCA recanalization after
thrombectomywith theMERCI retriever (goodness-of-fit test,
p =0.745; odds ratio 0.21 95 % CI 0.050–0.753; Wald test,
p =0.029).
The multiple logistic regression including the VolATD6>
27 ml and DWI>15 ml combined criterion, instead of the
ACG, and the use of a combination therapy, the presence of a
tandem occlusion and the time-to-IA-therapy higher than
240mn shows that the combined MR criterion is also the only
independent predictor of MCA recanalization after
thrombectomywith theMERCI retriever (goodness-of-fit test,
p =0.963; odds ratio 0.175 95 % CI 0.038–0.670; Wald test,
p =0.015).
The inclusion of VolATD6>27 ml and DWI>15 ml as two
separate dichotomized variables and of their interaction, in-
stead of the MRI combined criterion within the multivariable
logistic model, worsens this model.
In these multiple regression analyses, the choice to include
the dichotomized parameter time-to-IA-therapy>240 min in-
stead of the continuous corresponding variable is firstly due to
its non Gaussian and non normalizable distribution and sec-
ondly to the reported better outcome in patients who recana-
lize after thrombectomy within 300 min after stroke onset
[22]. The difference of 60 min between these two delays
corresponds to an estimation of the mean time needed to
achieve per-procedure MCA recanalization.
In addition, questioning a bias related to a possible link
between the year of the endovascular procedure and the MCA
recanalization rate, during the 9-year inclusion period, the
year of the thrombectomy was entered into these multivariate
analyses but does not modify their conclusions.
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Discussion
Previous studies already demonstrated that a non-invasive
collateral flow assessment is able to predict MCA-M1 recan-
alization after IV thrombolysis [7–9].
The current study demonstrates that a similar prediction is
possible in patients undergoing endovascular thrombectomy.
Indeed, in this series, the criterion combining baseline DWI
lesion volume and volume of tissue with arterial-tissue delay
over 6 s is significantly correlated with the angiographic
collateral grading, and significantly discriminates recanalizers
from non recanalizers after thrombectomy with the MERCI
retriever.
This is the first step toward a non-invasive prediction of
recanalization after thrombectomy. It provides the potential
opportunity to improve the penumbral imaging-based selec-
tion of patients for thrombectomy.
Indeed, the negative results of all the recent therapeutic
trials for thrombectomy not only suggest that the development
of more effective endovascular devices is imperative but also
that better selection of the patients could be a new strategy for
future trials [23–26]. The IMS III and SYNTHESIS Expan-
sion studies, that did not use mismatch-based imaging selec-
tion of patients, show that intravenous thrombolysis is still the
first-line treatment within 4.5 h after ischemic stroke onset,
even if imaging shows an occluded major intracranial artery
[23, 24]. Beyond 4.5 h, the MR RESCUE trial, whose sample
size is relatively small, does not provide data supporting the
use of endovascular treatment in patients with an ischemic
penumbra as defined in this study [25]. However, all these
trials used older retrieval devices with a significantly lower
recanalization rate compared with recent stent retrievers [20,
21]. Thus, the ischemic penumbra hypothesis tested in MR
RESCUE should be retested in a larger randomized trial with
more efficient recent retrievers [26]. Moreover, a recent study
also finds another explanation for negative results in the MR
RESCUE study. Indeed, authors of this study demonstrated
that, in patients treated with IV thrombolysis and/or
endovascular thrombectomy, prediction of tissue fate using
CT-based penumbral imaging cannot predict clinical outcome
without combining prediction of recanalization [27]. Similar-
ly, patients with a MRI-derived target mismatch profile,
hallmarking penumbra, have a more favorable clinical out-
come if reperfusion is achieved after thrombectomy [28].
However, if recanalization is not achieved, the penumbral
information becomes somewhat futile.
Thus, the prediction of recanalization and ultimately reper-
fusion is becoming a new challenge in the field of non-
invasive multimodal imaging aimed to improve the selection
of patients for recanalization therapies [27].
Fig. 1 Correlations between
Bayesian parameters, diffusion
lesion volume and the
angiographic collateral grading
(0–1 vs 2 vs 3–4) in the whole
cohort. VolATD6 and VolDWI




with smaller baseline volume of
tissue with severely increased
ATD and smaller baseline DWI
lesion volume (Spearman’s rank
correlation)
Table 3 Discrimination between grades 0–2 versus 3–4 in the whole
cohort
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Choice of the angiographic revascularization grading
In the SWIFT randomized controlled trial, a successful recan-
alization was defined as TICI 2 or greater reperfusion (Throm-
bolysis In Cerebral Infarction) [20]. However, in the current
study, the AOL scoring was preferred to evaluate the arterial
patency at the end of the procedure. AOL and TICI scores are
strongly correlated [13]. Moreover, measures performed after
the end of the thrombectomy procedure in the SWIFT trial,
including any rescue therapy, demonstrated that AOL 2–3,
TIMI 2–3 and TICI 2b–3 scores did not differ significantly in
predicting good neurological outcome (mRS 0–2 or equal to
baseline mRS if baseline mRS was greater than 2, or improve-
ment of at least 10 points in NIHSS score) (57, 62.9, 61.8 %,
respectively; AOL versus TIMI p =0.31, AOL versus TICI
p =0.095) [13].
In addition, in the SWIFT study, ratios of successful recan-
alization rate over good neurological outcome rate are very
close in patients treated with the SOLITAIRE device versus
those treated with the MERCI device (1.19 (69/58) and 0.91
(30/33), respectively) [20]. Thus, the prediction of a good
clinical outcome using the recanalization criterion seems in-
dependent of the thrombectomy device used which highlights
the interest of this prediction in the selection of patients for
thrombectomy. The aim of the current study is to perform a
non invasive prediction of recanalization through the assess-
ment of the collateral flow in patients mostly treated with the
MERCI retrieval device.
Correlations between MRI-derived parameters
and the angiographic collateral flow grading
All tested parameters are significantly correlated with the
ACG. However, VolATD6 and baseline DWI lesion volume
perform best (Fig. 1). Moreover, their corresponding optimal
thresholds tend to more accurately detect patients with excel-
lent collateral flow compared with optimal threshold of
VolATD+1.5SD (Table 3). The Youden’s index calculation
confirms higher discriminative performances of VolATD6 and
VolDWI thresholds by comparison with VolATD+1.5 thresh-
old (Youden’s index value=0.67, 0.66, 0.48 respectively).
Trends to discriminate recanalizers versus non recanalizers
are also better for VolATD6 and baseline DWI lesion volume
(Table 4). Therefore, only the combination of these two pa-
rameters was tested in an attempt to improve the MRI predic-
tion of MCA recanalization after thrombectomy.
Predictive value of baseline DWI lesion volume on MCA
recanalization
Raychev et al. recently reported that the baseline volume of
DWI abnormalities was an independent predictor of recanali-
zation after thrombectomy in a cohort of 105 patients with
ICA and MCA occlusion treated with multimodal mechanical
device strategies (MERCI±Penumbra±angioplasty and
stenting) (logistic regression analysis, OR=0.238, p =0.046)
[6].
In the current series including a smaller cohort of 57
patients with MCA±ICA occlusion mostly treated with the
MERCI retriever±IVT, the baseline DWI lesion volume
threshold >15 ml, accurately discriminating angio grades 0–
2 versus 3–4, only shows a trend to discriminate recanalizers
versus non recanalizers (Fisher’s exact test, p =0.056 in the
whole cohort) (Table 4).
Similarly, Olivot et al. [29] reported that patients with full
recanalization after endovascular therapy for MCA and/or
ICA occlusion (SNARE (eV3) or SOLITAIRE (Covidien)
devices, ±combined IV or IA rtPA) tend to have a smaller
baseline median DWI lesion volume versus patients with
partial or no recanalization (10, 21, and 19 ml respectively;
p =0.07). In this series, the largest DWI lesion volume asso-
ciated with a favorable outcome in non recanalizers was
relatively small and equal to 20 ml [29]. Although Olivot
et al. did not report the collateral flow status in these patients
[29], their observations are in agreement with the significant
relationship between the baseline DWI lesion volume and the
ACG demonstrated in the current study. Indeed, one could
expect that patients with MCA occlusion associated with an
excellent collateral flow, as suggested by a small baseline
DWI lesion volume, might have a favorable outcome in spite
of a persisting MCA occlusion.
Interestingly, in patients with similar arterial occlusions
treated with IVT, Nicoli et al. [7] and Nighogossian et al.
[30] reported a significantly smaller initial DWI lesion volume
Table 4 Discrimination between
recanalizers versus non
recanalizers in the whole cohort
and in the subpopulation of pa-
tients treated with the MERCI re-
triever only
a Two-tailed Fisher’s exact test
Whole cohort (n=57) MERCI cohort (n =50)
p valuea p valuea
VolATD6>27 ml 0.111 0.093
VolATD+1.5SD>159 ml 0.113 0.153
VolDWI>15 ml 0.056 0.121
VolATD6>27 ml and DWI>15 ml 0.032 0.024
Angio grade 0–1 vs 2–4 0.0054 0.011
Angio grade 0–2 vs 3–4 0.0069 0.015
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in recanalizers (mean value=13 ml and median value=13 ml,
respectively) versus non recanalizers (mean value=23.4 ml
and median value=48 ml, respectively).
Thus, whether MCA recanalization is obtained after IVT
[7, 30] or thrombectomy [29] recanalizers have a relatively
small baseline DWI lesion volume (# <20ml). In addition, this
range of baseline DWI lesion volume is significantly correlat-
ed with very good collateral perfusion.
Predictive value of Bayesian MR-PWI-derived collateral flow
index on MCA recanalization
The positive impact of the degree of collateral flow on MCA
recanalization after thrombectomy has already been demon-
strated [1, 2]. However, in the current series, despite a signif-
icant correlation with ACG and its very good diagnostic
accuracy for discriminating patients with or without very good
collateral flow (AUC=0.84), the baseline volume of tissue
with ATD>6 s. only shows a nonsignificant trend to predict
MCA M1 recanalization after thrombectomy (Fisher’s exact
test, p =0.111 in the whole cohort, p =0.093 in the MERCI
cohort) (Table 4); whereas the collateral grading alone, per-
formed later during angiography, is able to accurately discrim-
inate recanalizers from nonrecanalizers. Further investigations
are required to determine if the discrepancy between the
prediction of MCA recanalization by VolATD6 versus ACG
is related to an insufficient accuracy of the PWI-based collat-
eral flow assessment, and/or to fluctuations in hemodynamic
conditions and collateral supply during the MRI-to-
angiography time that would decrease the predictive value
of the VolATD6 measurement on later ACG and
recanalization.
Added value of DWI and PWI to predict recanalization
after thrombectomy
In the current series, the combination of VolATD6 and DWI
lesion volume measurements significantly discriminates
recanalizers from nonrecanalizers, whether patients are treated
with the MERCI retriever only or not (Table 4). These find-
ings suggest that these two parameters, significantly correlated
with the ACG, provide complementary and non redundant
information about the degree of collateral flow and its ability
to increase the full MCA recanalization rate. The highest
sensitivity of VolATD6 optimal threshold (100 %) combined
with the highest specificity of VolDWI optimal threshold
(85.7 %) for diagnosing very good collateral flow may con-
tribute to the better prediction of full MCA-M1 recanalization.
Indeed, the post hoc analysis of the correlation between these
two MR-derived collateral flow indices and the ACG (0–1 vs
2 vs 3–4) demonstrates that this correlation with the ACG is
higher for the combined criterion (VolATD6>27 ml:
Pearson’s chi square=12.75, Cramer’s V =0.47, p =0.0017;
DWI>15 ml: Pearson’s chi square=13.92, Cramer’s V =0.49,
p =0.0009; combined criterion: Pearson’s chi square=18.42,
Cramer’s V =0.57, p <0.0001). In addition, at the time of the
MRI examination, the VolATD6 measurement provides an
instantaneous estimation of the degree of collateral flow while
the DWI lesion volume corresponds to a tissue marker for the
efficiency of collateral perfusion to preserve tissue from is-
chemia during the time to MRI. Thus, the combined criterion
increases the MRI information content on the degree of col-
lateral flow and facilitates discrimination of recanalizers and
nonrecanalizers.
Moreover, like the angiographic collateral grading, this
combined criterion is an independent predictor of MCA re-
canalization after thrombectomy with the MERCI retriever.
Impact of the combined therapy on post-thrombectomy
recanalization
In patients with MCA-M1 occlusion treated with IVT within
the 3-h time window, the vigor of the collateral flow is
predictive of a full MCA recanalization [7]. Beyond 3 h,
collateral circulation does not significantly potentiate the ac-
tion of IV tPA on the clot, probably because the longer a clot
persists over time, the more resistant to fibrinolysis it becomes
[7]. However, even when failing to recanalize the occluded
artery, IVT performed before thrombectomy could be able to
(1) limit the thrombus extension by delivering rtPA to proxi-
mal and distal parts of the clot via efficient collaterals [7] and
(2) make the mechanical thrombectomy easier thanks to a
relatively lower clot size compared with thrombectomy alone.
Thus, the relationship between collateral flow and the
success of the thrombectomy procedure could only be driven
by IV rtPA. Interestingly, this bridging therapy was applied in
33 to 58 % of the cases treated with a stent retriever in SWIFT
and TREVO II trials [21].
However, in the current series, only 16 patients were treat-
ed with IVT and the MERCI retriever making difficult to
definitely conclude about the rational for the influence of the
vigor of the collateral flow on MCA recanalization in patients
treated with bridging therapy versus thrombectomy alone. The
frequency of this combined therapy was not statistically dif-
ferent in recanalizers versus nonrecanalizers (31.8 % (7/22)
and 32.1 % (9/28) respectively). In addition, the multivariate
analysis including the variable “combined therapy” demon-
strates that only the ACG and the combined MR criteria are
independent predictors of full MCA recanalization after
thrombectomy with the MERCI retriever.
How may the vigor of the collateral flow influence MCA
recanalization in patients treated with thrombectomy alone?
The answer to this question raised by the results of the afore-
mentioned multivariate analysis is more speculative and needs
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more investigations. Virchow’s triad is traditionally invoked
to explain pathophysiologic mechanisms leading to thrombo-
sis, alleging concerted roles for abnormalities in blood com-
position (e.g., platelet activation), endothelium injury, and
reduced blood flow in the development of arterial and venous
thrombosis [31]. Given this pathophysiology, one could sug-
gest that in patients treated with thrombectomy alone, a better
collateral flow decreases the relative importance of the re-
duced blood flow component of the Virchow’s triad within
the MCA vascular bed, which could limit the thrombus ex-
tension and make the thrombectomy procedure easier.
Similarly, Jovin et al. had previously suggested that pa-
tients with M1 or ICA terminus occlusion and severely
hypoperfused hemisphere have a higher proportion of ische-
mic core in which, because of stagnant flow, the vessels
supplying the area have a higher clot burden in the vascular
bed of the affected territory which decreases the probability of
recanalization [32]. Interestingly, these authors demonstrated
that the higher the regional CBF in the ipsilateral hemisphere,
the higher the likelihood of successful intra-arterial thrombol-
ysis [32]. Given the significant relationship between the ipsi-
lateral rCBF and the collateral flow deficit index VolATD6
(linear regression, negative correlation, r2=0.63; p <0.0001)
demonstrated in patients with MCA-M1 occlusion [8], the
results from Jovin et al. suggest that a good collateral flow
might also facilitate recanalization beyond 3 h during intra-
arterial thrombolysis, thanks to a potential lower clot burden
due to a reduced intravascular stagnant flow [7].
To sum up, the instantaneous estimation of the vigor of the
collateral flow is predictive of MCA recanalization when
performed just before the recanalization therapy, either by
means of PWI before IV thrombolysis [7–9] or by means of
angiography before thrombectomy [1, 2, current study].
By contrast, when the MRI-based collateral perfusion as-
sessment is performed before the endovascular procedure, the
time between this measurement and the reperfusion therapy is
longer and the instantaneous estimation of the vigor of the
collateral flow using a PWI-derived index is no longer effec-
tive alone to predict recanalization after a thrombectomy
performed later.
However, if this index is combined with the baseline DWI
lesion volume, predictions of the delayed angiographic collat-
eral grading and of post-thrombectomy recanalization are both
significantly improved.
The baseline DWI lesion volume has a strong prognostic
value for dependency, death and intracerebral hemorrhage in
patients with acute ischemic stroke including those who
underwent endovascular treatment [29, 33, 34]. It should also
be considered as an index of average reactivity of the collateral
supply in acute MCA M1 occlusion with potential hemody-
namic fluctuations during the onset-to-MRI time. Thus, it
might be more informative than a simple instantaneous mea-
surement of the collateral flow efficiency and an important
complementary functional parameter to take into account in a
MRI-based collateral supply assessment.
Limitations of the study
The first limitation is the retrospective design of the study.
However, patients analyzed in this series have been included
in a prospective clinical registry from one stroke center with
consistent and standardized medical care.
The 9-year inclusion period could be responsible for
learning-curve related biases, such as a higher recanalization
rate due to increased thrombectomy experience in the stroke
center. However, the multivariate analysis demonstrated that
this parameter was not an independent predictor of
recanalization.
Another limitation is the time elapsed between the MR
examination and the angiographic exploration. Indeed, fluc-
tuations in the degree of collateral flow may occur and impact
the correlations between early MR-PWI collateral flow as-
sessment and the later angiographic collateral grading [35,
36]. Although the relatively short mean MRI-to-angiography
time (Table 1) minimizes such bias, further prospective study
is warranted, also with a particular caution about the system-
atic registration of hemodynamic fluctuations occurring dur-
ing the MRI-to-angiography time.
In addition, the baseline DWI lesion volume threshold that
accurately identifies patients with excellent collateral flow in
the current study must not be extrapolated to patients with
MCA-M1 occlusion treated within a shorter onset-to-
treatment time. Indeed, within 3 h after stroke onset, the
baseline DWI lesion volume might be small in spite of a weak
collateral flow because the MRI was performed early during
the infarct growth. Conversely, the same small baseline DWI
lesion volume diagnosed beyond 3 h, a usual onset-to-
endovascular thrombectomy time, argues for a slow infarct
growth, more probably in relation with a good collateral flow.
Finally, the almost exclusive use of the MERCI retriever in
the current study impedes us to extrapolate the predictive
value of the combined criterion to predict MCA recanalization
after endovascular thrombectomy using other devices. Indeed,
it has been recently demonstrated that recanalization rate
depends on the retriever used for thrombectomy [20, 21].
Therefore, these results need to be confirmed in a larger cohort
of patients having undergone thrombectomy with different
retrievers.
Conclusions
The current study demonstrates that MR-PWI and DWI can
noninvasively assess the degree of collateral perfusion and
predict the rate of full recanalization of MCA-M1 occlusions
in patients treated with the MERCI retriever. Baseline DWI
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lesion volume and VolATD6 used in combination to achieve
such prediction are highly reproducible. This combined crite-
rion, closely correlated with the ACG, may improve and
promote the non-invasive selection of patients for
endovascular therapy, especially when coupled with a penum-
bral imaging able to select responders to recanalization. How-
ever, further studies are necessary to fully confirm our find-
ings and evaluate the accuracy of this method to predict MCA
recanalization with other models of retrieval devices.
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